Different Insulin Pens

FDA approves 1st rapid-acting insulin

According to the FDA, the medication quickly helps to lower mealtime blood sugar spikes to improve control of blood sugar in people with diabetes.

MarketWatch · 16h

FDA Approves First Rapid-Acting Insulin Biosimilar Product for Treatment of Diabetes

Agency Continues Efforts to Increase Access to Insulin Treatment Options SILVER SPRING, Md., /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Merilog (insulin-aspart-szjj) as biosimilar to Novolog (insulin aspart) for the improvement of glycemic control in adults and pediatric patients with diabetes mellitus.

Seeking Alpha on MSN · 14h

Sanofi gets FDA approval for NovoLog insulin biosimilar

Sanofi (NASDAQ:SNY) has received FDA approval for Merilog, a biosimilar of Novo Nordisk's (NVO) rapid-acting insulin product NovoLog, for the improvement of glycemic control in adults and children with diabetes mellitus.

Business Insider2y

This cooling wallet keeps insulin cold for 2 days and makes traveling as a diabetic more convenient — my dad takes his everywhere

Learn more As my family prepared recently for our first big vacation in several years, we ran into a problem: How would we keep my dad's insulin pens cold enough to avoid spoiling until we reached ...

Hosted on MSN9mon

Brits with diabetes fear they'll 'die within days' amid insulin crisis

There are many different types of insulin available and ... he had been unable to access his regular pre-filled Tresiba insulin pen 'for the last six prescriptions now'. Another, who was ...

pharmaphorum2d

Novo Nordisk launches first smart insulin pens for NHS patients

Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first ...

Medscape6d

A Review of 20 Years' Experience With the Novopen Family of Insulin Injection Devices

NovoPen ®, the first insulin pen injector, was introduced in 1985. This article reviews the published evidence over two decades of use of the NovoPen ® family of injection devices in diabetes ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results